Can B Corp. (CANB)
Stock analysis · OTC · Healthcare · Drug Manufacturers - Specialty & Generic
Can B Corp. (CANB) is a publicly traded company in the Healthcare sector. Latest price: $0.02. Market cap $1.49M. Trailing PE -0.11. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →You have viewed 5 SEO analysis pages
Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.
Continue with free signupEarnings
Proprietary Signals
About Can B Corp.
Can B Corp. operates within the United States, specializing in the development, manufacturing, and sale of products derived from cannabidiol (CBD). Its extensive range of hemp-based CBD offerings includes oils, topical creams, moisturizers, isolates, gel capsules, spa items, concentrates, and various lifestyle products. Customers can purchase these goods through the company's official website, automated vending machines, and via partnerships with medical professionals. The firm markets its products under distinct brand names such as Canbiola, Nu Wellness, Seven Chakras, and Pure Leaf Oil. The company, which changed its name from Canbiola Inc. to Can B Corp. in February 2020, was founded in 2005 and is headquartered in Hicksville, New York.
Valuation
| P/E (TTM) | -0.11× |
|---|---|
| P/S (TTM) | 0.00× |
| P/B | -0.09× |
| P/FCF (TTM) | -6.75× |
| EV / EBITDA | -1.28× |
| EV / Sales | 0.00× |
| Earnings Yield | -911.89% |
| Free Cash Flow Yield | -14.83% |
Fundamentals
| Enterprise Value | $9.79M |
|---|---|
| Net Income (TTM) | -$13.63M |
| Free Cash Flow (TTM) | $1.56M |
| Net Debt | $8.30M |
| Working Capital | -$12.74M |
| Gross Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
| Return on Equity | 148.68% |
| Return on Invested Capital | 107.66% |
Peers
Recent News
- No recent news available.
Related
Browse more tickers: sitemap